- Drug Discovery & Preclinical
- Monoclonal Antibodies
- Antibody-Drug Conjugates
- Vaccines (Prophylactic & Therapeutic)
- Cell & Gene Therapies (CGT)
- Allergy & Hypersensitivity
- Biomarker
- High-Dimensional Single-Cell Analysis by Flow Cytometry
- High-Throughput Cytokine & Chemokine Profiling by Multiplexing
- Biomarkers via Advanced IHC & Spatial Imaging
- Rare Cellular Functional Biomarkers by ELISPOT
- Real-Time Kinetic Biomarkers by IncuCyte S3
- Genomic Biomarker Analysis by qPCR & Droplet Digital PCR
- Seahorse XF: Immunometabolism & Bioenergetics
- MALDI Biotyper: Rapid Microbial & Proteomic Profiling
- Sapidyne KinExA
- Robust Protein Quantification by ELISA
- Advanced LNP Formulation & Screening – Unchained Labs Sunshine
- Translational & Clinical Research
- Immunogenicity Risk Assessment & Immunotoxicology
- Regulated Bioanalysis: PK, PD & Soluble Biomarkers
- Histopathology & Spatial Biology
- Advanced Flow Cytometry & Cellular Immunology
- Molecular Bioanalysis & Genomic Profiling
- Functional Potency & Ex Vivo Translational Models
- Central Laboratory & Clinical Trial Sample Management
- Dermo-Cosmetics & FMCG
- Nutraceuticals & Wellness
- Biorepository
Cytokine & Chemokine Analysis
We perform targeted and multiplex analysis of cytokines and chemokines to characterise immune activation, inflammatory responses, and biological signalling patterns. These analyses enable quantitative assessment of immune mediators across diverse biological matrices and experimental models. We Focus on
- Immune response profiling
- Inflammatory pathway assessment
- Comparative immune activation studies
- Functional response mapping
Assay design is guided by biological pathways and immune relevance, ensuring that selected analytes reflect meaningful physiological and mechanistic processes.
Low-Volume Biomarker Analysis
Our low-volume biomarker platforms enable high-quality protein analysis from limited sample inputs. This capability is particularly valuable for studies involving scarce biological material, micro-scale models, and low-yield sample matrices. This enables Biomarker analysis from limited sample volumes , Multi-analyte measurement from minimal inputs, Efficient use of valuable biological samples, Scalable analysis across multiple conditions
Low-volume workflows are designed to preserve data integrity while maximising analytical output from constrained sample availability.